385 related articles for article (PubMed ID: 16204787)
21. Influence of N-acetylcysteine on ICAM-1 expression and IL-8 release from endothelial and epithelial cells.
Radomska-Leśniewska DM; Sadowska AM; Van Overveld FJ; Demkow U; Zieliński J; De Backer WA
J Physiol Pharmacol; 2006 Sep; 57 Suppl 4():325-34. PubMed ID: 17072061
[TBL] [Abstract][Full Text] [Related]
22. Effects of inhaled HFA beclomethasone on pulmonary function and symptoms in patients with chronic obstructive pulmonary disease.
John M; Bosse S; Oltmanns U; Schumacher A; Witt C
Respir Med; 2005 Nov; 99(11):1418-24. PubMed ID: 15894479
[TBL] [Abstract][Full Text] [Related]
23. Bronchodilator reversibility, airway eosinophilia and anti-inflammatory effects of inhaled fluticasone in COPD are not related.
Reid DW; Wen Y; Johns DP; Williams TJ; Ward C; Walters EH
Respirology; 2008 Nov; 13(6):799-809. PubMed ID: 18811878
[TBL] [Abstract][Full Text] [Related]
24. [Acetylcysteine in the treatment of severe COPD].
Dekhuijzen PN
Ned Tijdschr Geneeskd; 2006 Jun; 150(22):1222-6. PubMed ID: 16796172
[TBL] [Abstract][Full Text] [Related]
25. Inhaled sodium pyruvate improved FEV1 and decreased expired breath levels of nitric oxide in patients with chronic obstructive pulmonary disease.
Votto JJ; Bowen JB; Barton RW; Thrall RS
J Aerosol Med Pulm Drug Deliv; 2008 Dec; 21(4):329-34. PubMed ID: 18800883
[TBL] [Abstract][Full Text] [Related]
26. The effect of different treatment modalities on oxidative stress in COPD.
Kuleci S; Hanta I; Kocabas A; Canacankatan N
Adv Ther; 2008 Jul; 25(7):710-7. PubMed ID: 18592146
[TBL] [Abstract][Full Text] [Related]
27. [The study of inflammatory mediators and pulmonary ventilatory capacity in patients with chronic obstructive pulmonary disease].
He B; Zhao MW; Wang YZ; Liu XF; Yao WZ
Zhonghua Jie He He Hu Xi Za Zhi; 2003 Jan; 26(1):22-5. PubMed ID: 12775264
[TBL] [Abstract][Full Text] [Related]
28. Effect of cetirizine dihydrochloride on the airway response to hypertonic saline aerosol in patients with chronic obstructive pulmonary disease (COPD).
Grönke L; Schlenker J; Holz O; Out TA; Magnussen H; Jörres RA
Respir Med; 2005 Oct; 99(10):1241-8. PubMed ID: 16140224
[TBL] [Abstract][Full Text] [Related]
29. Correlation of oxidative status with BMI and lung function in COPD.
Vibhuti A; Arif E; Deepak D; Singh B; Qadar Pasha MA
Clin Biochem; 2007 Sep; 40(13-14):958-63. PubMed ID: 17631288
[TBL] [Abstract][Full Text] [Related]
30. Effects of different anti-asthmatic agents on induced sputum and eosinophil cationic protein in mild asthmatics.
Basyigit I; Yildiz F; Kacar Ozkara S; Boyaci H; Ilgazli A; Ozkarakas O
Respirology; 2004 Nov; 9(4):514-20. PubMed ID: 15612964
[TBL] [Abstract][Full Text] [Related]
31. Serum and bronchial lavage fluid concentrations of IL-8, SLPI, sCD14 and sICAM-1 in patients with COPD and asthma.
Hollander C; Sitkauskiene B; Sakalauskas R; Westin U; Janciauskiene SM
Respir Med; 2007 Sep; 101(9):1947-53. PubMed ID: 17574828
[TBL] [Abstract][Full Text] [Related]
32. Antioxidant effect of zinc picolinate in patients with chronic obstructive pulmonary disease.
Kirkil G; Hamdi Muz M; Seçkin D; Sahin K; Küçük O
Respir Med; 2008 Jun; 102(6):840-4. PubMed ID: 18295467
[TBL] [Abstract][Full Text] [Related]
33. Pharmacological investigation on the anti-oxidant and anti-inflammatory activity of N-acetylcysteine in an ex vivo model of COPD exacerbation.
Cazzola M; Calzetta L; Facciolo F; Rogliani P; Matera MG
Respir Res; 2017 Jan; 18(1):26. PubMed ID: 28118826
[TBL] [Abstract][Full Text] [Related]
34. [Inhaled corticosteroids for COPD].
Dekhuijzen PN
Ned Tijdschr Geneeskd; 2003 Jul; 147(29):1398-404. PubMed ID: 12894463
[TBL] [Abstract][Full Text] [Related]
35. Modulation of neutrophil and inflammation markers in chronic obstructive pulmonary disease by short-term azithromycin treatment.
Parnham MJ; Culić O; Eraković V; Munić V; Popović-Grle S; Barisić K; Bosnar M; Brajsa K; Cepelak I; Cuzić S; Glojnarić I; Manojlović Z; Novak-Mircetić R; Oresković K; Pavicić-Beljak V; Radosević S; Sucić M
Eur J Pharmacol; 2005 Jul; 517(1-2):132-43. PubMed ID: 15964564
[TBL] [Abstract][Full Text] [Related]
36. Oral N-acetylcysteine attenuates pulmonary emphysema and alveolar septal cell apoptosis in smoking-induced COPD in rats.
Cai S; Chen P; Zhang C; Chen JB; Wu J
Respirology; 2009 Apr; 14(3):354-9. PubMed ID: 19341424
[TBL] [Abstract][Full Text] [Related]
37. The effect of inhaled corticosteroids on bronchoalveolar lavage cells and IL-8 levels in stable COPD patients.
Ozol D; Aysan T; Solak ZA; Mogulkoc N; Veral A; Sebik F
Respir Med; 2005 Dec; 99(12):1494-500. PubMed ID: 15946834
[TBL] [Abstract][Full Text] [Related]
38. Modulation of operational lung volumes with the use of salbutamol in COPD patients accomplishing upper limbs exercise tests.
Porto EF; Castro AA; Nascimento O; Oliveira RC; Cardoso F; Jardim JR
Respir Med; 2009 Feb; 103(2):251-7. PubMed ID: 18930646
[TBL] [Abstract][Full Text] [Related]
39. Effects of atorvastatin added to inhaled corticosteroids on lung function and sputum cell counts in atopic asthma.
Hothersall EJ; Chaudhuri R; McSharry C; Donnelly I; Lafferty J; McMahon AD; Weir CJ; Meiklejohn J; Sattar N; McInnes I; Wood S; Thomson NC
Thorax; 2008 Dec; 63(12):1070-5. PubMed ID: 18757458
[TBL] [Abstract][Full Text] [Related]
40. Benefits and risks of adjunctive inhaled corticosteroids in chronic obstructive pulmonary disease: a meta-analysis.
Sobieraj DM; White CM; Coleman CI
Clin Ther; 2008 Aug; 30(8):1416-25. PubMed ID: 18803985
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
